Comparative Efficacy of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Vs. Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRD) in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

被引：0

作者：

Wang, Yuqi ^{[1
]}

Huan, Chen ^{[2
]}

Hanzhen, Zhang

Zhang, Shanshan ^{[3
]}

Yuan, Youhai ^{[1
]}

Feng, Ru ^{[4
]}

Wei, Yongqiang ^{[3
]}

Wei, Xiaolei ^{[3
]}

机构：

[1] Nanfang Hosp, Guangzhou, Peoples R China

[2] Southern Med Univ, Guangzhou, Peoples R China

[3] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China

[4] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China

来源：

关键词：

D O I：

10.1182/blood-2024-205810

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7031 / 7031

页数：1